Bayer AG (BAYZF)
57.35
+1.18
(+2.09%)
USD |
OTCM |
Aug 25, 16:00
Bayer Total Assets (Quarterly) : 122.66B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 122.66B |
| March 31, 2026 | 124.37B |
| December 31, 2025 | 129.90B |
| September 30, 2025 | 122.45B |
| June 30, 2025 | 123.53B |
| March 31, 2025 | 117.94B |
| December 31, 2024 | 121.97B |
| September 30, 2024 | 119.36B |
| June 30, 2024 | 128.46B |
| March 31, 2024 | 129.47B |
| December 31, 2023 | 136.25B |
| September 30, 2023 | 124.13B |
| June 30, 2023 | 132.74B |
| March 31, 2023 | 135.86B |
| December 31, 2022 | 139.69B |
| September 30, 2022 | 128.34B |
| June 30, 2022 | 134.65B |
| March 31, 2022 | 139.95B |
| December 31, 2021 | 144.17B |
| September 30, 2021 | 135.12B |
| June 30, 2021 | 135.41B |
| March 31, 2021 | 139.31B |
| December 31, 2020 | 150.02B |
| September 30, 2020 | 140.16B |
| June 30, 2020 | 138.90B |
| Date | Value |
|---|---|
| March 31, 2020 | 137.68B |
| December 31, 2019 | 147.32B |
| September 30, 2019 | 142.47B |
| June 30, 2019 | 146.11B |
| March 31, 2019 | 146.37B |
| December 31, 2018 | 150.77B |
| September 30, 2018 | 151.59B |
| June 30, 2018 | 160.68B |
| March 31, 2018 | 92.73B |
| December 31, 2017 | 92.25B |
| September 30, 2017 | 90.69B |
| June 30, 2017 | 94.26B |
| March 31, 2017 | 90.97B |
| December 31, 2016 | 90.09B |
| September 30, 2016 | 86.01B |
| June 30, 2016 | 83.85B |
| March 31, 2016 | 87.32B |
| December 31, 2015 | 84.64B |
| September 30, 2015 | 83.13B |
| June 30, 2015 | 84.30B |
| March 31, 2015 | 82.34B |
| December 31, 2014 | 90.60B |
| September 30, 2014 | 76.57B |
| June 30, 2014 | 75.22B |
| March 31, 2014 | 77.81B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck KGaA | 60.24B |
| Breakthrough Chemistry, Inc. | 1.300M |
| Cardiac Biotech Solutions, Inc. | 0.5053M |
| Fresenius SE & Co. KGaA | 47.84B |
| Carl Zeiss Meditec AG | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 88.69B |
| Shareholders Equity (Quarterly) | 33.82B |
| Debt to Equity Ratio | 1.299 |
| Current Ratio | 1.043 |
| Net Debt Paydown Yield | -0.52% |